Watson S A, Crosbee D M, Dilks K L, Robertson J F, Hardcastle J D
Cancer Research Campaign Laboratories, University of Nottingham, U.K.
Anticancer Res. 1993 Jan-Feb;13(1):97-102.
The gastrointestinal tumour cell lines, MKN45G and C146 possessed oestrogen receptors (ER) of affinities 1.8 x 10(-8) and 5.2 x 10(-9) M respectively. C146 and MKN45G had enhanced proliferation in the presence of oestradiol (10(-8) and 10(-10) M). Fifty-six percent (5/9) of primary gastric and colorectal tumours had their proliferation enhanced by oestradiol. The anti-steroidal drug, danazol, inhibited the basal growth of MKN45G (10 micrograms ml-1 45% of the untreated control), C146 (10 and 5 micrograms ml-1, 20 and 48% of control, respectively) and 3/9 GI primary tumours (10 micrograms ml-1). Danazol competed with 3 [H]-Oestradiol for binding to ER on MKN45G and C146, at concentrations from 10 to 1 micrograms ml-1.
胃肠道肿瘤细胞系MKN45G和C146分别具有亲和力为1.8×10⁻⁸和5.2×10⁻⁹M的雌激素受体(ER)。在存在雌二醇(10⁻⁸和10⁻¹⁰M)的情况下,C146和MKN45G的增殖增强。56%(5/9)的原发性胃癌和结直肠癌的增殖因雌二醇而增强。抗甾体药物达那唑抑制MKN45G的基础生长(10微克/毫升,为未处理对照的45%)、C146的基础生长(10和5微克/毫升,分别为对照的20%和48%)以及3/9的胃肠道原发性肿瘤的基础生长(10微克/毫升)。达那唑在浓度为10至1微克/毫升时与³[H] - 雌二醇竞争结合MKN45G和C146上的ER。